# Nevro receives FDA approval for Costa Rica manufacturing operations

Nevro Corp. received FDA approval for its new manufacturing facility in Coyol Free Trade Zone, Alajuela, Costa Rica, for production of spinal cord stimulation systems. The company invested approximately $21 million and expects to begin shipping by end of October 2022.

- Type: New facility
- Announced: 2022-10-04
- Where: Coyol Free Trade Zone, Alajuela, Costa Rica, Costa Rica
- Value: $21.0M
- Jobs: 100
- Starts operating: Oct 2022
- Status: under construction
- Products: spinal cord stimulation systems, HFX product platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Nevro](https://endata.com/companies/49893.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/nevro-announces-fda-approval-of-costa-rica-manufacturing-operations-301640861.html), 2022-10-04: "We are pleased that the FDA has approved our new global manufacturing operations in Costa Rica."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.